Looking Beyond Weight Loss: The Future of Obesity Care
As the understanding of obesity science evolves, focus is shifting from simply reducing body weight to treating obesity as a complex, chronic disease affecting almost every system of the body.
Looking Beyond Weight Loss: The Future of Obesity Care
As the understanding of obesity science evolves, focus is shifting from simply reducing body weight to treating obesity as a complex, chronic disease affecting almost every system of the body.
How Pfizer Is Rethinking What’s Possible in Cancer Care
For people living with cancer and those who love them, every moment matters. Cancer remains one of the greatest healthcare challenges of our lifetime, and Pfizer is working with urgency to transform scientific advances into potential life-changing medicines.
How Pfizer Is Rethinking What’s Possible in Cancer Care
For people living with cancer and those who love them, every moment matters. Cancer remains one of the greatest healthcare challenges of our lifetime, and Pfizer is working with urgency to transform scientific advances into potential life-changing medicines.
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).
Rewriting the Obesity Narrative
Over millions of years, humans got remarkably good at storing excess energy as fat. To survive perilous stretches of scarcity and famine, our brains evolved to view calorie-dense foods as highly rewarding, and our biology encourages us to eat as much as possible when we encounter them.
Rewriting the Obesity Narrative
Over millions of years, humans got remarkably good at storing excess energy as fat. To survive perilous stretches of scarcity and famine, our brains evolved to view calorie-dense foods as highly rewarding, and our biology encourages us to eat as much as possible when we encounter them.
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says. Then he got sick.
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says. Then he got sick.
Looking Beyond Weight Loss: The Future of Obesity Care
As the understanding of obesity science evolves, focus is shifting from simply reducing body weight to treating obesity as a complex, chronic disease affecting almost every system of the body.
Looking Beyond Weight Loss: The Future of Obesity Care
As the understanding of obesity science evolves, focus is shifting from simply reducing body weight to treating obesity as a complex, chronic disease affecting almost every system of the body.
How Pfizer Is Rethinking What’s Possible in Cancer Care
For people living with cancer and those who love them, every moment matters. Cancer remains one of the greatest healthcare challenges of our lifetime, and Pfizer is working with urgency to transform scientific advances into potential life-changing medicines.
How Pfizer Is Rethinking What’s Possible in Cancer Care
For people living with cancer and those who love them, every moment matters. Cancer remains one of the greatest healthcare challenges of our lifetime, and Pfizer is working with urgency to transform scientific advances into potential life-changing medicines.
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).
Rewriting the Obesity Narrative
Over millions of years, humans got remarkably good at storing excess energy as fat. To survive perilous stretches of scarcity and famine, our brains evolved to view calorie-dense foods as highly rewarding, and our biology encourages us to eat as much as possible when we encounter them.
Rewriting the Obesity Narrative
Over millions of years, humans got remarkably good at storing excess energy as fat. To survive perilous stretches of scarcity and famine, our brains evolved to view calorie-dense foods as highly rewarding, and our biology encourages us to eat as much as possible when we encounter them.
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says. Then he got sick.
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says. Then he got sick.